“USE OF GLP-1 RECEPTOR AGONISTS IN THE TREATMENT OF OBESITY: CLINICAL EVIDENCE AND NUTRITIONAL IMPLICATIONS”, REMUNOM, vol. 21, no. 05, pp. 1–11, Dec. 2025, doi: 10.61164/dgpn4685.